KARS1
KARS1 (lysyl-tRNA synthetase 1, also known as KARS, KARS2 and DFNB89) is a class II aminoacyl-tRNA synthetase that charges tRNAs with lysine. It is a homodimeric enzyme, and the KARS1 gene has also been linked to autoimmunity and HIV-1 biology. Browse Assay Genie's current range of KARS1 research reagents below, or read on for the biology behind the target.
KARS1 belongs to the aminoacyl-tRNA synthetases, a class of enzymes that charge tRNAs with their cognate amino acids. Lysyl-tRNA synthetase is a homodimer and a member of the class II family of tRNA synthetases. Its annotated activities include lysine--tRNA ligase activity (EC 6.1.1.6) and a second activity listed under EC 2.7.7.-. The KARS1 protein is localised mainly to the cytoplasm, and UniProt also records it in the cytosol, nucleus, cell membrane, secreted fraction and mitochondrion.
In the context of microbial infection, UniProt reports that KARS1 interacts with the HIV-1 GAG protein. This interaction facilitates the selective packaging of tRNA(3)(Lys), the primer for initiation of reverse transcription. The enzyme is therefore of interest beyond protein synthesis, in studies of how a virus uses host translation machinery.
KARS1 has been shown to be a target of autoantibodies in the human autoimmune diseases polymyositis and dermatomyositis. Alternatively spliced transcript variants encoding different isoforms have been reported for the gene. The HGNC symbol KARS1 replaces the earlier symbols KARS and KARS2, and the previous gene name was lysyl-tRNA synthetase. The alias DFNB89 reflects an earlier name, deafness, autosomal recessive 89. Orthologues are annotated in mouse and rat, both as Kars1.
KARS1 is a class II aminoacyl-tRNA synthetase that charges tRNAs with lysine, making it a reference enzyme for studying tRNA aminoacylation.
KARS1 is a target of autoantibodies in polymyositis and dermatomyositis, so it is relevant to studies of autoantigens in these diseases.
KARS1 interacts with HIV-1 GAG and helps package tRNA(3)(Lys), the primer for reverse transcription, linking host synthetases to viral replication.
KARS1 is annotated in the cytosol, nucleus, cell membrane, secreted fraction and mitochondrion, which makes it useful for studying how one synthetase is distributed across compartments.
KARS1 is a lysine--tRNA ligase. As an aminoacyl-tRNA synthetase, it charges tRNAs with their cognate amino acid, here lysine. It functions as a homodimer in the cytoplasm. UniProt also reports an interaction with HIV-1 GAG that supports packaging of tRNA(3)(Lys) into virions.
KARS1 is also known as KARS, KARS2 and DFNB89, and as lysyl-tRNA synthetase or lysine--tRNA ligase. DFNB89 comes from the earlier name deafness, autosomal recessive 89. Alternatively spliced transcript variants encoding different isoforms have been described for the gene.
Mouse and rat both have a Kars1 orthologue. KARS1 is a target of autoantibodies in the autoimmune diseases polymyositis and dermatomyositis. Check the datasheet of any product for its validated reactivity.
Other aminoacyl-tRNA synthetases, autoantigens in myositis and HIV-1 associated proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15046; product specifications from Assay Genie datasheets.